Skip to main navigation
Skip to search
Skip to main content
UTMB Health Research Expert Profiles Home
Help & FAQ
Home
Experts
Departments
Equipment
Projects/Grants
Publications
Activities
Press/Media
Honors
Search by expertise, name or affiliation
Recent developments in leishmaniasis
Peter C. Melby
Research output
:
Contribution to journal
›
Review article
›
peer-review
44
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Recent developments in leishmaniasis'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Leishmania
100%
Leishmaniasis
100%
Vaccine Candidate
50%
Next-generation Vaccines
50%
Parasite Virulence
50%
Health Problems
25%
Overexpression
25%
Vaccine Potential
25%
Interleukin-10
25%
Macrophages
25%
Experimental Animal Studies
25%
Interleukin-4 (IL-4)
25%
Cutaneous Leishmaniasis
25%
Effector Function
25%
Clinical Trials
25%
Interleukin-12 (IL-12)
25%
Translational Research
25%
Host Defense
25%
Clinical Evaluation
25%
Alternative Therapy
25%
Diagnostic Test
25%
Protozoan Parasites
25%
Clinical Treatment
25%
Solid Foundation
25%
Experimental Animal Models
25%
CD8+ T Cells
25%
Recent Advances
25%
Disease Pathogenesis
25%
Dendritic Cells
25%
Drug Therapy
25%
Disease Progression
25%
Diagnostic Interventions
25%
Parasite Biology
25%
Determinants of Disease
25%
Gene Knockout
25%
HIV Co-infection
25%
CD4 T Cells
25%
Gene number
25%
Genetic Heterogeneity
25%
Reintroduction
25%
Resistant Cases
25%
Miltefosine
25%
Host Treatment
25%
Lipophosphoglycan
25%
Antimony
25%
Liposomal Amphotericin B
25%
Clonal Diversity
25%
DNA Diagnostics
25%
Pharmacology, Toxicology and Pharmaceutical Science
Disease
100%
Leishmaniasis
100%
Leishmania
100%
Clinical Trial
50%
Experimental Animal
50%
Parasite Virulence
50%
HIV
25%
Skin Leishmaniasis
25%
Pharmacotherapy
25%
Preclinical Study
25%
Clinical Study
25%
Protozoon
25%
Visceral Leishmaniasis
25%
Interleukin 10
25%
Interleukin 4
25%
Mixed Infection
25%
CD8 Antigen
25%
Amphotericin
25%
Miltefosine
25%
Lipophosphoglycan
25%
Immunology and Microbiology
Leishmaniasis
100%
Leishmania
100%
Experimental Animal
50%
Parasite Virulence
50%
Human Immunodeficiency Virus
25%
Animal Experiment
25%
Cutaneous Leishmaniasis
25%
Macrophage
25%
Visceral Leishmaniasis
25%
T-Helper Cell
25%
Host Resistance
25%
Preclinical Study
25%
Interleukin 4
25%
Interleukin 10
25%
Cytotoxic T-Cell
25%
Protozoa
25%
Coinfection
25%
Gene Knockout
25%
Dendritic Cell
25%
Gene Targeting
25%
Lipophosphoglycan
25%
Genetic Heterogeneity
25%
Parasitology
25%